AbbVie picks Unilife for syringes; Indian regulator criticizes the 'lackadaisical attitude' of companies;

> Unilife has won a $5 million contract from AbbVie ($ABBV) for development and supply of prefilled syringes and reusable auto-injectors for certain drugs in its "portfolio for the treatment of autoimmune diseases." Filing

> A state regulator in India has warned the industry that some of its problems with the FDA stem from a "lackadaisical attitude of the pharma industry personnel which also include senior management officials." Report

> U.S.-based pharma manufacturing and lab equipment maker SP Industries has acquired privately held Stability Environments for an undisclosed sum. Report

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.